DDIT3 and diffuse large B-cell lymphoma: Conversely, the inhibition of miR-21 and miR-155 by miRNA inhibitors significantly increased the cytotoxic effect of the CHOP regime or doxorubicin and rituximab, respectively, in human DLBCL or BL cell lines.